New study aims to predict Crohn's treatment success with simple scans
NCT ID NCT07246460
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well the drug guselkumab works in adults with Crohn's disease. Researchers will use intestinal ultrasound and blood tests to measure response over one year. The goal is to find better ways to track treatment success without invasive procedures. About 90 participants will be enrolled.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN'S DISEASE OF BOTH SMALL AND LARGE INTESTINE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Calgary
RECRUITINGCalgary, Alberta, T3H 1S7, Canada